Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2012, Article ID 465089, 4 pages
http://dx.doi.org/10.1155/2012/465089
Case Report

Fatal CMV-Infection after Autologous Stem Cell Transplantation in Refractory Systemic Lupus Erythematosus

13rd Department of Medicine, Institute for Medicine, Medical and Health Science Center, University of Debrecen, Móricz Zs. krt. 22, Debrecen 4032, Hungary
2Division of Clinical Immunology and Rheumatology, National Institute for Rheumatology and Physiotherapy, Frankel Leó Strasse 25-29, Budapest H-1023, Hungary

Received 20 November 2011; Accepted 26 January 2012

Academic Editor: C. Costa

Copyright © 2012 László Váróczy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Cervera, M. A. Khamashta, J. Font et al., “Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients: European working party on systemic lupus erythematosus,” Medicine, vol. 78, no. 3, pp. 167–175, 1999. View at Google Scholar
  2. K. Takada, G. G. Illei, and D. T. Boumpas, “Cyclophosphamide for the treatment of systemic lupus erythematosus,” Lupus, vol. 10, no. 3, pp. 154–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Lee and A. Kavanaugh, “Biologic agents in rheumatology: safety considerations,” Rheumatic Disease Clinics of North America, vol. 32, supplement1, pp. 3–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Tyndall and R. Saccardi, “Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions,” Clinical and Experimental Immunology, vol. 141, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. de Buys, D. Khanna, and D. E. Furst, “Hemopoietic stem cell transplantation in rheumatic diseases—an update,” Autoimmunity Reviews, vol. 4, no. 7, pp. 442–449, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Jayne, “Stem cell transplantation in systemic lupus erythematosus,” Best Practice and Research, vol. 17, no. 2, pp. 291–304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. K. Burt, A. Traynor, L. Statkute et al., “Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus,” Journal of the American Medical Association, vol. 295, no. 5, pp. 527–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. G. Illei and S. Z. Pavletic, “Blood stem cells as therapy for severe lupus,” Expert Opinion on Biological Therapy, vol. 5, no. 9, pp. 1153–1164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Marmont and R. Burt, “Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases,” Autoimmunity, vol. 41, no. 8, pp. 639–647, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Hebart and H. Einsele, “Clinical aspects of CMV infection after stem cell transplantation,” Human Immunology, vol. 65, no. 5, pp. 432–436, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Boeckh, R. A. Bowden, T. Gooley, D. Myerson, and L. Corey, “Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients,” Blood, vol. 93, no. 5, pp. 1781–1782, 1999. View at Google Scholar · View at Scopus
  12. H. Einsele, G. Ehninger, H. Hebart et al., “Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation,” Blood, vol. 86, no. 7, pp. 2815–2820, 1995. View at Google Scholar · View at Scopus
  13. P. Reusser, R. Attenhofer, H. Hebart, C. Helg, B. Chapuis, and H. Einsele, “Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants,” Blood, vol. 89, no. 10, pp. 3873–3879, 1997. View at Google Scholar · View at Scopus
  14. L. A. Holmberg, M. Boeckh, H. Hooper et al., “Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation,” Blood, vol. 94, no. 12, pp. 4029–4035, 1999. View at Google Scholar · View at Scopus